- Home
- MNOV vs RBOT Comparison
MNOV vs RBOT Comparison
Compare MNOV & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNOV | RBOT |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 16.1M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNOV | RBOT |
|---|---|---|
| Price | $1.31 | $2.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | $7.00 | $7.00 |
| AVG Volume (30 Days) | 80.9K | ★ 174.3K |
| Earning Date | 02-18-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $257,917.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.13 | $1.81 |
| 52 Week High | $2.20 | $18.97 |
Technical Indicators
Market Signals| Indicator | MNOV | RBOT |
|---|---|---|
| Relative Strength Index (RSI) | 35.86 | 37.79 |
| Support Level | $1.25 | $1.81 |
| Resistance Level | $1.34 | $2.33 |
| Average True Range (ATR) | 0.05 | 0.20 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 18.50 | 36.23 |
Price Performance
Historical ComparisonAbout MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.